1 unknown, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 1, Withdrawn 1 |
Follow Cataract Diabetic: new trials by email Literature Review of Cataract Diabetic trials Research Report on Cataract Diabetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy Ranibizumab Injection [Lucentis], Phacoemulsification - Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic | Phase 4 | Unknown | Ruijin Hospital | 96 | 2022-07-01 | 2022-05-23 |
| Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp - Cataract Diabetic, Macula Edema | Phase 4 | Withdrawn | Baylor Research Institute | 2021-08-31 | 2026-03-02 |
Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Endocrine System Diseases (1) · Eye Diseases (1) · Retinal Diseases (1) · Vascular Diseases (1)
Calcium Dobesilate (1) · Phacoemulsification (1) · Ranibizumab (1) · prednisolone acetate (1)
Baylor Research Institute (1) · Ruijin Hospital (1)
China (1)
Zijian Yang, Dr (1)